Published in Int Rev Neurobiol on January 01, 2011
Development of allosteric modulators of GPCRs for treatment of CNS disorders. Neurobiol Dis (2013) 1.20
Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice. Biochem Pharmacol (2013) 0.90
Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease. Mov Disord (2013) 0.84
Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson's disease. J Pharmacol Exp Ther (2013) 0.83
Recent advances in the management of choreas. Ther Adv Neurol Disord (2013) 0.77
The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease. Neuropharmacology (2012) 0.77
Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes on behavior of dyskinesia rats. Biol Res (2016) 0.75
Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes. Front Neurol (2015) 0.75
Neuroprotective effects of Eucommia ulmoides Oliv. and its bioactive constituent work via ameliorating the ubiquitin-proteasome system. BMC Complement Altern Med (2015) 0.75
Brittle Dyskinesia Following STN but not GPi Deep Brain Stimulation. Tremor Other Hyperkinet Mov (N Y) (2014) 0.75
The preoperative neurological evaluation. Neurohospitalist (2013) 0.75
Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. JAMA (2002) 4.36
The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol (2013) 2.65
Bilateral pallidal stimulation for Wilson's disease. Mov Disord (2013) 1.98
Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic. J Neurol Neurosurg Psychiatry (2012) 1.54
Coordinated reset has sustained aftereffects in Parkinsonian monkeys. Ann Neurol (2012) 1.42
FXTAS: new insights and the need for revised diagnostic criteria. Neurology (2012) 1.39
A genetic screening strategy identifies novel regulators of the proteostasis network. PLoS Genet (2011) 1.19
Canadian Guidelines on Parkinson's Disease. Can J Neurol Sci (2012) 1.15
Caregiving by family and friends of adults receiving dialysis. Nephrol Nurs J (2006) 1.02
Normal cerebrovascular reactivity in Stroke-like Migraine Attacks after Radiation Therapy syndrome. Clin Nucl Med (2010) 1.02
Multiple system atrophy: current and future approaches to management. Ther Adv Neurol Disord (2010) 1.02
Measuring mild cognitive impairment in patients with Parkinson's disease. Mov Disord (2013) 1.00
Coordinated reset neuromodulation for Parkinson's disease: proof-of-concept study. Mov Disord (2014) 1.00
Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) experience. J Interv Cardiol (2002) 0.91
Subthalamic deep brain stimulation increases pallidal firing rate and regularity. Exp Neurol (2011) 0.91
Associated movement disorders in orthostatic tremor. J Neurol Neurosurg Psychiatry (2012) 0.90
Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease. Dement Geriatr Cogn Disord (2013) 0.87
Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group. Mov Disord (2014) 0.85
Dihydropyridine calcium channel blockers and the progression of parkinsonism. Ann Neurol (2012) 0.85
Psychiatric comorbidities in dystonia: emerging concepts. Mov Disord (2013) 0.85
Progressive supranuclear palsy: in vivo SPECT imaging of presynaptic vesicular acetylcholine transporter with [123I]-iodobenzovesamicol. Radiology (2012) 0.83
Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time. Parkinsonism Relat Disord (2012) 0.82
Antidepressants and psychosis in Parkinson disease: a case series. Int J Geriatr Psychiatry (2007) 0.80
Relevance of corpus callosum splenium versus middle cerebellar peduncle hyperintensity for FXTAS diagnosis in clinical practice. J Neurol (2014) 0.79
Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy. Mov Disord (2014) 0.79
Wilson disease: Canadian perspectives on presentation and outcomes from an adult ambulatory setting. Can J Gastroenterol (2012) 0.79
[(123)I]-IBVM SPECT imaging of cholinergic systems in multiple system atrophy: A specific alteration of the ponto-thalamic cholinergic pathways (Ch5-Ch6). Neuroimage Clin (2013) 0.78
Deep brain stimulation changes basal ganglia output nuclei firing pattern in the dystonic hamster. Neurobiol Dis (2010) 0.78
High frequency stimulation of the entopeduncular nucleus sets the cortico-basal ganglia network to a new functional state in the dystonic hamster. Neurobiol Dis (2009) 0.78
Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities--a multicenter phase II trial. Lung Cancer (2005) 0.77
The pill questionnaire in a nondemented Parkinson's disease population. Mov Disord (2012) 0.76
Developing a new faculty practice plan with a model for funds flow between the hospital and the plan. Acad Med (2003) 0.76
Ambiguous mechanisms of dysphagia in multiple system atrophy. Brain (2011) 0.75
Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over ("n-of-1") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients. Parkinsonism Relat Disord (2012) 0.75
Treating neurological Wilson's disease; the expert opinion is not good enough. Can J Neurol Sci (2013) 0.75
Dyspnea as first sign of autonomic failure in postmortem confirmed multiple system atrophy. Mov Disord (2010) 0.75
Chorea--an unusual manifestation in a woman recovering from myxedema coma. Endocr Pract (2012) 0.75
Facial emotion recognition is inversely correlated with tremor severity in essential tremor. J Neural Transm (Vienna) (2013) 0.75
The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease. Parkinsonism Relat Disord (2012) 0.75
Restless legs syndrome in multiple system atrophy. J Neural Transm (Vienna) (2014) 0.75
The translational value of the MPTP non-human primate model of Parkinsonism for deep brain stimulation research. Conf Proc IEEE Eng Med Biol Soc (2011) 0.75
[Multiple system atrophy]. Psychol Neuropsychiatr Vieil (2010) 0.75
A cross-sectional study on drug use in multiple system atrophy. CNS Drugs (2014) 0.75